GEN Exclusives

More »

GEN News Highlights

Back to Item »

BeiGene Inks Co-Development and Licensing Deals for Two of Janssen’s Anticancer Candidates

Chinese firm will co-develop intetumumab antibody and negotiated global rights to macrocyclic kinase inhibitor MTKi-327.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Alzheimer's Therapies

Do you think an effective treatment for Alzheimer’s will be found within the next 10–15 years?